The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 23, 2022
Filed:
Feb. 10, 2020
Applicant:
Wex Medical Limited, Wanchai, HK;
Inventors:
Helmut Heinrich Buschmann, Barcelona, ES;
Jose Miguel Vela Hernandez, Barcelona, ES;
Jose Manuel Baeyens, Granada, ES;
Assignee:
WEX MEDICAL LIMITED, Kowloon, HK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/529 (2006.01); A61K 31/337 (2006.01); A61K 31/475 (2006.01); A61K 31/517 (2006.01); A61K 31/52 (2006.01); A61K 33/243 (2019.01); A61K 33/24 (2019.01); A61K 45/06 (2006.01); A61K 31/519 (2006.01);
U.S. Cl.
CPC ...
A61K 31/529 (2013.01); A61K 31/337 (2013.01); A61K 31/475 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61K 31/52 (2013.01); A61K 33/24 (2013.01); A61K 33/243 (2019.01); A61K 45/06 (2013.01);
Abstract
The present invention refers to the use of sodium channel blockers such as tetrodotoxin or saxitoxin, its analogues/derivatives as well as their acceptable salts, for the production of a medicament for the treatment of neuropathic pain resulting from chemotherapy.
Buschmann, Helmut. (2022). Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy (U.S. Patent No. 11419873). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11419873
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile